p-hydroxybenzenesulfinic acid | 3724-13-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: p-hydroxybenzenesulfinic acid
• 英文别名: 4-hydroxybenzenesulfinic acid；p-phenolsulfinic acid；p-toluolsulfin acid
• CAS: 3724-13-8
• 化学式: C₆H₆O₃S
• 分子量: 158.178
• InChiKey: FDHHGMAXJRGHET-UHFFFAOYSA-N

物化性质

• 熔点：
  67-70 °C (decomp)
• 沸点：
  431.9±47.0 °C(Predicted)
• 密度：
  1.66±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  76.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  p-hydroxybenzenesulfinic acid 在 双氧水 作用下， 以 重水 为溶剂， 生成 4-羟基苯磺酸
  参考文献：
  名称：

  Sulfinic acids and related compounds. 24. Monothioquinone S,S-dioxides and their relation to convergent syntheses involving hydroxyarenesulfonyl chlorides

  摘要：

  DOI：

  10.1021/jo00295a062
• 作为产物：
  描述：

  sodium p-hydroxybenzenesulfonate 在 三乙胺 、 4-甲苯硫酚 作用下， 生成 p-hydroxybenzenesulfinic acid
  参考文献：
  名称：

  固相合成亚磺酸薄荷酯和亚砜

  摘要：

  对羟基苯磺酸亚锡酯很容易与Wang树脂连接。生成的亚磺酸盐与格氏试剂和烯醇钾或烯醇锂反应生成相应的亚砜或β-酮亚砜，从而可以研究用于固相合成的亚砜的化学性质。

  DOI：

  10.1016/s0040-4039(01)01978-5

文献信息

• [EN] HEPATITIS B VIRAL ASSEMBLY EFFECTORS<br/>[FR] EFFECTEURS D'ASSEMBLAGE DE VIRUS DE L'HÉPATITE B
  申请人：UNIV INDIANA RES & TECH CORP

  公开号：WO2016168619A1

  公开（公告）日：2016-10-20

  Novel assembly effector compounds having a therapeutic effect against hepatitis B viral (HBV) infection are disclosed. Assembly effector molecules described herein can lead to defective viral assembly and also may affect other viral activities associated with chronic HBV infection. Also disclosed is a process to synthesize disclosed compounds, method of treatment of HBV by administration of disclosed compounds, and use of these compounds in the manufacture of medicaments against HBV.

  揭示了一种对乙型肝炎病毒（HBV）感染具有治疗效果的新型组装效应子化合物。本文描述的组装效应子分子可以导致病毒组装缺陷，也可能影响与慢性HBV感染相关的其他病毒活动。还公开了一种合成所述化合物的方法，通过给予所述化合物治疗HBV的方法，以及利用这些化合物制造针对HBV的药物的用途。
• Polymerizable composition, optical material comprising the composition and method for producing the material
  申请人：——

  公开号：US20040254258A1

  公开（公告）日：2004-12-16

  A cured matter obtained by polymerizing and curing a polymerizable composition comprising a compound having at least one episulfide in a molecule is reduced in an odor by adding a perfume to the polymerizable composition comprising the compound having at least one episulfide in a molecule. A cloudiness of the lens is removed by raising a purity of sulfur to 98% or more. A reduction in a chlorine content of the sulfur compound described above to 0.1% by weight or less elevates an oxidation resistance and a light fastness of the high refractive index optical material and improves a color tone thereof. An optical product having a high refractive index and a high-degree transparency is provided by subjecting the composition in advance to deaerating treatment at 0 to 100° C. for one minute to 24 hours under a reduced pressure of 0.001 to 50 torr.

  通过聚合和固化至少含有一种环硫醚的化合物的可聚合组合物获得的治愈物质，通过向至少含有一种环硫醚的化合物的可聚合组合物中添加香水来减少其气味。通过将硫的纯度提高到98％或更高，可以消除镜片的混浊。将上述硫化合物的氯含量降低至0.1％或更低可以提高高折射率光学材料的氧化抗性和耐光性，并改善其色调。通过在0至100°C下将组合物事先进行脱气处理，以在0.001至50 torr的减压下持续1分钟至24小时，可提供具有高折射率和高度透明度的光学产品。
• POLYMERIZABLE COMPOSITION, OPTICAL MATERIAL COMPRISING THE COMPOSITION AND METHOD FOR PRODUCING THE MATERIAL
  申请人：MITSUBISHI GAS CHEMICAL COMPANY, INC.

  公开号：EP1524289A1

  公开（公告）日：2005-04-20

  A cured matter obtained by polymerizing and curing a polymerizable composition comprising a compound having at least one episulfide in a molecule is reduced in an odor by adding a perfume to the polymerizable composition comprising the compound having at least one episulfide in a molecule. A cloudiness of the lens is removed by raising a purity of sulfur to 98 % or more. A reduction in a chlorine content of the sulfur compound described above to 0.1 % by weight or less elevates an oxidation resistance and a light fastness of the high refractive index optical material and improves a color tone thereof. An optical product having a high refractive index and a high-degree transparency is provided by subjecting the composition in advance to deaerating treatment at 0 to 100°C for one minute to 24 hours under a reduced pressure of 0.001 to 50 torr.

  通过聚合和固化包含分子中至少含有一种表硫化物的化合物的可聚合组合物而获得的固化物，可通过向包含分子中至少含有一种表硫化物的化合物的可聚合组合物中添加香料来减少气味。 将硫的纯度提高到 98% 或更高，可消除镜片的浑浊度。 将上述硫化合物的氯含量降低到 0.1%（重量百分比）或更低，可提高高折射率光学材料的抗氧化性和耐光性，并改善其色调。 在 0.001 至 50 托的减压条件下，将组合物预先在 0 至 100°C 的温度下进行 1 分钟至 24 小时的脱气处理，可获得具有高折射率和高透明度的光学产品。
• POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME
  申请人：LG Chem, Ltd.

  公开号：EP3476833A1

  公开（公告）日：2019-05-01

  The present specification relates to a heterocyclic compound of Chemical Formula 1 and an organic light emitting device including the same.

  本说明书涉及一种化学式 1 的杂环化合物和包括该杂环化合物的有机发光器件。
• Hepatitis B viral assembly effectors
  申请人：Indiana University Research and Technology Corporation

  公开号：US10273228B2

  公开（公告）日：2019-04-30

  Novel assembly effector compounds having a therapeutic effect against hepatitis B viral (HBV) infection are disclosed. Assembly effector molecules described herein can lead to defective viral assembly and also may affect other viral activities associated with chronic HBV infection. Also disclosed is a process to synthesize disclosed compounds, method of treatment of HBV by administration of disclosed compounds, and use of these compounds in the manufacture of medicaments against HBV.

  本研究公开了对乙型肝炎病毒（HBV）感染有治疗作用的新型组装效应化合物。本文所述的组装效应分子可导致病毒组装缺陷，还可影响与慢性 HBV 感染相关的其他病毒活动。还公开了合成所公开化合物的工艺、通过服用所公开化合物治疗 HBV 的方法，以及这些化合物在制造抗 HBV 药物中的用途。